NCT00564421View on ClinicalTrials.gov

Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648)

PHASE3CompletedINTERVENTIONAL
Enrollment

798

Participants

Timeline

Start Date

December 18, 2007

Primary Completion Date

February 14, 2008

Study Completion Date

February 14, 2008

Conditions
Seasonal Allergic Rhinitis
Interventions
DRUG

epinastine nasal spray, low concentration, low dose volume

2 sprays in each nostril, dosed twice a day

OTHER

placebo nasal spray

2 sprays in each nostril, dosed twice a day

DRUG

epinastine nasal spray, low concentration, high dose volume

2 sprays in each nostril, dosed twice a day

DRUG

epinastine nasal spray, high concentration, low dose volume

2 sprays in each nostril, dosed twice a day

DRUG

epinastine nasal spray, high concentration, high dose volume

2 sprays in each nostril, dosed twice a day

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00564421 - Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648) | Biotech Hunter | Biotech Hunter